CIK 0001192448 · Large accelerated filer
GLAUKOS Corp
Sign in to watch- Ticker
- GKOS
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-367-9600
- Business address
- 1 GLAUKOS WAY, ALISO VIEJO, CA, 92656
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,953,066
- in 7 filings, $743K under 10b5-1 plans
Net −$14,953,066. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-10 | Navratil Tomas CHIEF DEVELOPMENT OFFICER | Sale 10b5-1 | −32 | $120.23 | $4K | 90,370 |
| 2026-03-25 | Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,511 | $106.46 | $267K | 41,967 |
| 2026-03-24 | Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,521 | $105.24 | $160K | 46,498 |
| 2026-03-17 | Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −625 | $99.15 | $62K | 49,249 |
| 2026-03-16 | Navratil Tomas CHIEF DEVELOPMENT OFFICER | Sale | −460 | $97.33 | $45K | 74,202 |
| 2026-03-16 | Navratil Tomas CHIEF DEVELOPMENT OFFICER | Sale | −299 | $98.21 | $29K | 73,903 |
| 2026-03-16 | Navratil Tomas CHIEF DEVELOPMENT OFFICER | Sale | −272 | $99.05 | $27K | 73,631 |
| 2026-02-19 | WEISNER AIMEE S Director | Sale | −2,153 | $115.69 | $249K | 31,653 |
| 2026-02-19 | WEISNER AIMEE S Director | Sale | −5,242 | $116.64 | $611K | 26,411 |
| 2026-02-19 | WEISNER AIMEE S Director | Sale | −1,134 | $117.33 | $133K | 25,277 |
| 2026-02-19 | WEISNER AIMEE S Director | Sale | −6,471 | $118.56 | $767K | 18,806 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −2,406 | $126.10 | $303K | 100,458 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −3,100 | $127.03 | $394K | 97,358 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −1,798 | $128.07 | $230K | 95,560 |
| 2026-01-22 | Gilliam Joseph E PRESIDENT & COO | Sale 10b5-1 | −3,194 | $129.28 | $413K | 92,366 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −3,812 | $126.07 | $481K | 48,637 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −3,892 | $126.96 | $494K | 44,745 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −1,671 | $127.92 | $214K | 43,074 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −4,325 | $129.11 | $558K | 38,749 |
| 2026-01-22 | Stapley Marc Director | Sale 10b5-1 | −1,300 | $129.78 | $169K | 37,449 |
Page 3 of 8 · 153 trades